Volume 8, Issue 8, Pages (August 2000)

Slides:



Advertisements
Similar presentations
Volume 7, Issue 12, Pages (January 1999)
Advertisements

Volume 8, Issue 12, Pages (December 2000)
Crystal structure of the chemotaxis receptor methyltransferase CheR suggests a conserved structural motif for binding S-adenosylmethionine  Snezana Djordjevic,
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 9, Issue 2, Pages (February 2002)
Eeva K. Leinala, Peter L. Davies, Zongchao Jia  Structure 
Volume 14, Issue 3, Pages (March 2001)
Volume 3, Issue 9, Pages (September 1995)
Crystal structure of mammalian purple acid phosphatase
Volume 21, Issue 9, Pages (September 2013)
Structure of RGS4 Bound to AlF4−-Activated Giα1: Stabilization of the Transition State for GTP Hydrolysis  John J.G. Tesmer, David M. Berman, Alfred G.
Tamas Yelland, Snezana Djordjevic  Structure 
Volume 8, Issue 2, Pages (August 2001)
Volume 3, Issue 11, Pages (November 1995)
UG Wagner, M Hasslacher, H Griengl, H Schwab, C Kratky  Structure 
Volume 23, Issue 7, Pages (July 2015)
Volume 5, Issue 3, Pages (March 1997)
Volume 14, Issue 5, Pages (May 2007)
Phosducin induces a structural change in transducin βγ
Volume 4, Issue 3, Pages (March 1996)
Volume 8, Issue 3, Pages (March 2000)
Catalytic Center Assembly of HPPK as Revealed by the Crystal Structure of a Ternary Complex at 1.25 Å Resolution  Jaroslaw Blaszczyk, Genbin Shi, Honggao.
Crystal Structures of a Novel Ferric Reductase from the Hyperthermophilic Archaeon Archaeoglobus fulgidus and Its Complex with NADP+  Hsiu-Ju Chiu, Eric.
Crystal Structure of the Human High-Affinity IgE Receptor
Volume 31, Issue 2, Pages (July 2008)
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 4, Issue 5, Pages (November 1999)
Volume 16, Issue 10, Pages (October 2008)
Volume 84, Issue 2, Pages (February 2003)
Stacy D Benson, Jaana K.H Bamford, Dennis H Bamford, Roger M Burnett 
Crystal Structure of the λ Repressor C-Terminal Domain Provides a Model for Cooperative Operator Binding  Charles E. Bell, Paolo Frescura, Ann Hochschild,
Volume 9, Issue 8, Pages (August 2001)
Daniel Peisach, Patricia Gee, Claudia Kent, Zhaohui Xu  Structure 
Volume 8, Issue 6, Pages (June 2000)
Volume 2, Issue 8, Pages (August 1994)
Edith Schlagenhauf, Robert Etges, Peter Metcalf  Structure 
Volume 6, Issue 3, Pages (March 1998)
Volume 91, Issue 5, Pages (November 1997)
Volume 3, Issue 5, Pages (May 1999)
Crystal Structure of the Borna Disease Virus Nucleoprotein
Crystallographic Analysis of the Recognition of a Nuclear Localization Signal by the Nuclear Import Factor Karyopherin α  Elena Conti, Marc Uy, Lore Leighton,
Structures of Two Repeats of Spectrin Suggest Models of Flexibility
The basis for K-Ras4B binding specificity to protein farnesyl-transferase revealed by 2 Å resolution ternary complex structures  Stephen B Long, Patrick.
Volume 87, Issue 2, Pages (October 1996)
Masaru Goto, Rie Omi, Noriko Nakagawa, Ikuko Miyahara, Ken Hirotsu 
Transformation of MutL by ATP Binding and Hydrolysis
Activation Mechanism of the MAP Kinase ERK2 by Dual Phosphorylation
Tianjun Zhou, Liguang Sun, John Humphreys, Elizabeth J. Goldsmith 
Structural Basis of Rab Effector Specificity
Volume 3, Issue 3, Pages (March 1995)
Volume 4, Issue 5, Pages (May 1996)
Volume 85, Issue 5, Pages (May 1996)
Crystal Structure of the N-Terminal Domain of Sialoadhesin in Complex with 3′ Sialyllactose at 1.85 Å Resolution  A.P. May, R.C. Robinson, M. Vinson,
Crystal structure of the apoptotic suppressor CrmA in its cleaved form
Volume 91, Issue 5, Pages (November 1997)
Structure of a water soluble fragment of the ‘Rieske’ iron–sulfur protein of the bovine heart mitochondrial cytochrome bc1 complex determined by MAD phasing.
Volume 5, Issue 10, Pages (October 1997)
The Crystal Structure of an Unusual Processivity Factor, Herpes Simplex Virus UL42, Bound to the C Terminus of Its Cognate Polymerase  Harmon J Zuccola,
Hideki Kusunoki, Ruby I MacDonald, Alfonso Mondragón  Structure 
The Structure of JNK3 in Complex with Small Molecule Inhibitors
Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP+ molecule and provides insights into enzyme deficiency  Shannon.
Stacy D Benson, Jaana K.H Bamford, Dennis H Bamford, Roger M Burnett 
Pingwei Li, Gerry McDermott, Roland K. Strong  Immunity 
Structure of an IκBα/NF-κB Complex
Volume 8, Issue 8, Pages (August 2000)
Volume 4, Issue 3, Pages (March 1996)
Structural and Biochemical Analysis of the Obg GTP Binding Protein
The Crystal Structure of an Unusual Processivity Factor, Herpes Simplex Virus UL42, Bound to the C Terminus of Its Cognate Polymerase  Harmon J Zuccola,
Electrostatic activation of Escherichia coli methionine repressor
Luhua Lai, Hisao Yokota, Li-Wei Hung, Rosalind Kim, Sung-Hou Kim 
Presentation transcript:

Volume 8, Issue 8, Pages 863-874 (August 2000) Crystal structure and functional dissection of the cytostatic cytokine oncostatin M  Marc C Deller, Keith R Hudson, Shinji Ikemizu, Jerónimo Bravo, E Yvonne Jones, John K Heath  Structure  Volume 8, Issue 8, Pages 863-874 (August 2000) DOI: 10.1016/S0969-2126(00)00176-3

Figure 1 The structure of hOSM. (a) Refined coordinates and 2|Fo|–|Fc|αcalc electron-density map of hOSM contoured at 1σ showing density for the kinked region of helix A centred on Thr27. CNTF and LIF also have kinks owing to disruption of the mainchain hydrogen bonding around residues Thr32 and Ser36, respectively [19,20]. Both these residues bind water molecules through the Oγ1 atom to provide a substitute hydrogen-bond network similar to the pattern observed here for hOSM involving residue Thr27. (b) Ribbon diagram of hOSM coloured from blue at the N terminus through to red at the C terminus. Disulphide bonds are represented as ball-and-stick models with the sulphur atoms highlighted as yellow spheres. The transparent dotted section represents the CD loop as observed in LIF. (c) Stereodiagram of the Cα trace for hOSM. Structure 2000 8, 863-874DOI: (10.1016/S0969-2126(00)00176-3)

Figure 2 Structural comparisons. (a) From left to right the structures of human OSM, LIF (PDB entry code 1EMR), CNTF (1CNT) and IL-6 (1ALU) are shown in equivalent orientations. Each is represented as a ribbon coloured blue at the N terminus through to red at the C terminus. Helix A (blue) is kinked in OSM, LIF and CNTF whereas helix C (light green/yellow) is only significantly kinked in OSM. Of the interhelical loops, only the relatively short BC loop is well determined in all the structures. This region in hOSM has a five-residue insertion that protrudes from the top of the four-helix bundle. Both LIF and hOSM have a disulphide bridge anchoring an α-helical N-terminal portion of the AB loop to the top of helix D, whereas in IL-6 the loop is anchored to helix B. The AB loop in CNTF lacks any such tether and was thus too mobile to be accurately modelled in the crystal structure. The CD loop has not been fully modelled for hOSM and CNTF, although the orientation of residues preceding this loop suggests a similar route is taken to that of LIF, IL-6 and CNTF. (b) Comparison of surface charge between hOSM, LIF, CNTF and IL-6. Blue denotes positive and red negative; electrostatic potential is contoured at ±8.5 kT using the program GRASP [53]. The orientation is as in (a). (c) Surface charge comparisons are displayed as in (b) but viewed directly onto the top of the four-helix bundle. Structure 2000 8, 863-874DOI: (10.1016/S0969-2126(00)00176-3)

Figure 3 Functional binding data for hOSM muteins. (a) Competitive inhibition of biotinylated OSM binding to gp130–Fc by site 2 OSM muteins. (b) Biological activity of OSM muteins in the Ba/F3–LIFR/gp130 assay. (c) Biological activity of OSM muteins in the Ba/F3–OSMR/gp130 assay. (d) Competitive inhibition of biotinylated OSM binding to LIFR–Fc by site 3 OSM muteins. (e) Biological activity of OSM muteins in the Ba/F3–LIFR/gp130 assay. (f) Biological activity of OSM muteins in the Ba/F3–OSMR/gp130 assay. Structure 2000 8, 863-874DOI: (10.1016/S0969-2126(00)00176-3)

Figure 4 Structural mapping of binding sites 2 and 3 for hOSM. (a) Ribbon representation of hOSM with solvent-exposed residues studied by mutagenesis depicted in ball-and-stick representation. The solvent-accessible surface of hOSM in the regions of (b) site 2 and (c) site 3 with areas contributed by the mutagenised residues highlighted as coloured patches. For site 2 the orientation is as in (a) for site 3 the view is on to the top of the four-helix bundle. Residues not implicated in gp130 binding are in light-blue, those with some effect are yellow, residues critical for gp130 binding are green and those critical for LIFR binding are red. Structure 2000 8, 863-874DOI: (10.1016/S0969-2126(00)00176-3)

Figure 5 Complimentarity between the interaction surfaces of hOSM and gp130. The solvent-accessible surfaces of site 2 on hOSM (left) and the cognate binding site on gp130 (right) are displayed with areas contributed by residues implicated in binding highlighted as coloured patches. The orientation for hOSM site 2 is rotated 90° from that in Figure 4 whereas gp130 is rotated by 180° from its orientation relative to hOSM in the putative interaction complex, as in the opening of a book. Structure 2000 8, 863-874DOI: (10.1016/S0969-2126(00)00176-3)